How Ed Helps Clients
Edward John Allera, co-chair of the firm's FDA group, counsels clients on new product development and business opportunities in the areas of pharmaceuticals, hi-tech products, medical devices, food and cosmetics.
Ed has devoted his entire career to health care, as both a pharmacist and an attorney. He began his career at the Food and Drug Administration (FDA), where he served as associate chief counsel. Because of his ability to integrate science and the law, Ed has become highly-respected by clients in the pharma/biotech industry as the person to call in a “make-or-break” situation.
Ed’s expertise has also been recognized at the highest levels within the industry, including his recent appointment to the board of the FDA’s Reagan-Udall Foundation, the highly regarded not-for-profit created by Congress to advance regulatory science and technology in support of the FDA’s mission. As a board member, Ed joins a high-profile list of life sciences leaders including former FDA Commissioners, global biotech executives and CMS health policy administrators.
Ed has been selected by his peers for inclusion in The Best Lawyers in America© since 2021 in the area of FDA Law. Additionally, Ed was recognized as a leading Healthcare: Pharmaceutical/ Medical Products Regulatory lawyer in Washington, DC by Chambers USA in 2022 and 2023.
What Clients Can Expect
Clients rely on Ed for his ability to combat overreaching FDA actions. He and the cadre of attorneys and scientists with whom he works are able to quickly generate sophisticated legal and scientific rebuttals to FDA actions. Ed and his team have also assisted clients in dealing with the Office of the Inspector General of the Department of Health and Human Services, the Department of Justice, Congress, Centers for Medicare and Medicaid Services (CMS) and numerous state officials.
Ed uses his keen historic and contemporary industry and business perspectives to assist clients in complete product life cycle management. Because he has a background in the science surrounding nearly all dosage forms and the dynamics of translational science, he has filed a large number of Citizen Petitions in the product life cycle management process.
Our clients need us to win for them. With the FDA and other health care regulators and legislators, sometimes that means playing defense, and sometimes offense. You need strength in both.
On the compliance side, in an era when the FDA is taking a very hard line, Ed’s experience in dealing with most of FDA's field districts, as well as officials at FDA headquarters, helps clients be successful within the complex maze of compliance and keep abreast of potentially damaging regulatory impacts to their business.
Because he is a former managing partner in the firm’s D.C. office, Ed has been able to orchestrate and build a coordinated team that seamlessly integrates members from other practice groups such as federal district court litigation, corporate finance & technology, intellectual property and most importantly, government relations & public policy.
What does Ed enjoy most about his role at Buchanan? The opportunity to work on new and creative scientific issues. “Our FDA/ Biotech team doesn’t work on the mundane. We get cutting edge projects,” Ed says. No doubt because of Ed’s contagious passion for the industry he supports, two of his four children have followed him into the healthcare related fields.
Georgetown University Law Center, J.D., 1974
West Virginia University, B.S., 1969, Pharmacy
- District of Columbia
- U.S. District Court for the District of Maryland
Convalo Health International, Board Member
District of Columbia Bar
Reagan-Udall Foundation, Board Member
West Virginia University College of Pharmacy Hall of Fame
Knights of Columbus, Member